Skip to main content

Table 2 Baseline demographics of lung cancer patients with and without idiopathic pulmonary fibrosis (IPF) from institution, and lung cancer in overall population of state of Pennsylvania

From: Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data

Variables

Lung cancer with IPF

Lung cancer without IPF (institutional data)

Lung cancer without IPF (population data)

p-values column 1 vs. 3

N

Results

N

Results

N

Results

Age in years, median (IQR)

31

65 (62–71)

4176

67 (60–75)

104,954

69 (61–77)

0.03

Gender (% male)

31

19 (61%)

4176

2023 (48%)

104,954

53,800 (51%)

0.16

Ethnicity (% Caucasian)

31

30 (97%)

4176

3679 (88%)

104,954

89,643 (85%)

0.07

Smoking – never

31

7 (23%)

4176

395 (10%)

NA

< 0.001 (column 1 vs 2)

former

24 (77%)

2362 (57%)

current

0

1361 (33%)

Mortality over observation period (%)

31

26 (84%)

4176

2644 (63%)

104,954

78,254 (75%)

0.2

Survival time in months, median (IQR)

26

5 (1–10)

4176

13 (6–26)

NA

NA

0.002 (column 1 vs 2)

  1. Definition of abbreviations: IQR Interquartile range. Column 1 = Lung cancer with IPF; column 2 = Lung cancer with non-IPF ILD; column 3 = Lung cancer in general population in Pennsylvania. NA not available. Survival time was calculated by the time from lung cancer diagnosis to the date of expiration, or the time of registry data review